Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.6000+0.1300 (+2.91%)
At close: 04:00PM EDT
4.6000 0.00 (0.00%)
After hours: 07:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
5,140
3,662
250,734
44,674
Cost of revenue
13,737
38,857
5,396
2,978
Gross profit
-8,597
-35,195
245,338
41,696
Operating expenses
Research development
274,249
319,946
587,956
582,413
Selling general and administrative
159,407
209,969
286,896
271,362
Total operating expenses
433,656
529,915
874,852
853,775
Operating income or loss
-442,253
-565,110
-629,514
-812,079
Total other income/expenses net
10,403
1,851
-34
-12,835
Income before tax
-431,041
-562,380
-618,009
-790,153
Income tax expense
96
258
686
-545
Income from continuing operations
-431,137
-562,638
-618,695
-789,608
Net income
-453,862
-819,378
-618,695
-789,608
Net income available to common shareholders
-453,862
-819,378
-618,695
-789,608
Basic EPS
-
-11.89
-9.95
-14.31
Diluted EPS
-
-11.89
-9.95
-14.31
Basic average shares
-
68,190
62,178
55,191
Diluted average shares
-
68,190
62,178
55,191
EBITDA
-
-545,461
-610,158
-794,645